Fake Medicines Continue to Threaten Consumers – EU Member States have an Obligation to Act
According to The Alliance for Safe Online Pharmacy in the EU (ASOP EU), the illegal manufacturing and distribution of fake medicines is an enormous and growing public health risk with an untold cost to lives. "Vast profits are made by organized criminal gangs who often use the proceeds to support other criminal activities.
The Internet provides the ideal channel to buy illegally distributed fake medicines. Price, convenience and secrecy have driven consumer demand, creating the perfect environment for over 35,000 illegally operating websites."
Under article 85d of the Falsified Medicines Directive, each EU Member State is obliged to raise awareness about the risks of buying medicines online.
To better understand how countries are meeting these obligations to educate and protect consumers, the European Union’s Alliance for Safe Online Pharmacy (ASOP EU) and the European Alliance for Access to Safe Medicines (EAASM), has convened a series of discussions with many Member States. Based on these meetings, ASOP EU and EAASM have today issued a report, “FIGHTING FAKES BY MEMBER STATES – Falsified Medicines and the Common Logo – Raising Public Awareness. ” The report provides a detailed snapshot of the progress each EU Member State has made to educate the public about the risks of buying medicines on the Internet.
The full press release can be accessed on the ASOP website .
ABOUT ASOP EU
The Alliance for Safe Online Pharmacy in the EU (ASOP EU) is a not for profit Community Interest Company and represents a multi-sectorial, coalition of organisations and individuals, dedicated to creating an environment that enables patients to buy their medicines online safely (where it is legal to do so). To find out more about ASOP EU and ASOP Global please visit the website www.buysaferx.pharmacy
The European Alliance for Access to Safe Medicines (EAASM) is a not for profit Community Interest Company whose members strive to ensure patients are aware of falsified and sub-standard medicines and unsafe medical practices and that national governments have put in place mechanisms to protect the public. To find out more about the EAASM please visit the website www.eaasm.eu
For ASOP EU and EAASM:
Ashley Tapp / Deborah Bell
firstname.lastname@example.org / email@example.com
For ASOP Global:
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
MOODY’S-ANALYTICS22.6.2018 09:02 | pressemeddelelse
Wealthify Selects Moody’s Analytics Modeling Technology to Support Its Online Investment Proposition
LOXAM-GROUP/NO.VE.22.6.2018 09:02 | pressemeddelelse
Loxam Announces the Acquisition of Italian Powered Access Rental Specialist Nove
CA-OPENGATE-CAPITAL22.6.2018 08:02 | pressemeddelelse
OpenGate Capital Completes Sale of NorPaper Group to Gemayel Freres & Chaoui Industriel Group
PA-WESTINGHOUSE-ELECTRIC21.6.2018 22:26 | pressemeddelelse
First Westinghouse AP1000® Nuclear Plant Sanmen 1 Completes Initial Criticality
PA-WESTINGHOUSE-ELECTRIC21.6.2018 22:09 | pressemeddelelse
Westinghouse Loads Fuel in Second AP1000® Nuclear Power Plant
PHARNEXT21.6.2018 20:25 | pressemeddelelse
Pharnext to Announce Top-Line Results from the Pivotal Phase 3 Trial of PXT3003 for the Treatment of Charcot-Marie-Tooth Type 1A Disease by October 2018
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum